Aayush Wellness Valuation

Q: What is the Fair Price of 539528 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

539528 (₹134.5) is trading above our estimate of [[fair value]] (₹28.47)

Is 539528 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 539528 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 539528 (₹134.5) is trading above our estimate of fair value (₹28.47)

Significantly Below Fair Value: 539528 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 539528?

Key metric: As 539528 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 539528. This is calculated by dividing 539528's market cap by their current revenue.
What is 539528's PS Ratio?
PS Ratio	17.2x
Sales	₹253.61m
Market Cap	₹4.28b

539528 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	16.8x
Enterprise Value/EBITDA	315.2x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 539528's PS Ratio compare to its peers?

The above table shows the PS ratio for 539528 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	5.3x
JHS JHS Svendgaard Laboratories	2.2x	n/a	₹1.9b
531412 Radix Industries (India)	6.7x	n/a	₹2.5b
530843 Cupid	12.1x	n/a	₹22.6b
530689 Lykis	0.2x	n/a	₹811.4m
539528 Aayush Wellness	17.2x	n/a	₹4.3b

Price-To-Sales vs Peers: 539528 is expensive based on its Price-To-Sales Ratio (17.2x) compared to the peer average (5.3x).

Price to Sales Ratio vs Industry

How does 539528's PS Ratio compare vs other companies in the IN Personal Products Industry?

5 Companies	Price / Sales	Estimated Growth	Market Cap
530689 Lykis	0.2x	n/a	US$9.61m
524703 Sandu Pharmaceuticals	0.8x	n/a	US$6.58m
542248 Deccan Health Care	0.8x	n/a	US$6.55m
WALPAR Walpar Nutritions	0.6x	n/a	US$4.73m

5 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 539528 is expensive based on its Price-To-Sales Ratio (17.2x) compared to the Indian Personal Products industry average (7x).

Price to Sales Ratio vs Fair Ratio

What is 539528's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

539528 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	17.2x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 539528's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Dabur India

₹900.7b

Operates as a fast-moving consumer goods company worldwide.

DABUR

₹508.20

-0.5%

-6.1%

Jyothy Labs

₹148.6b

Engages in the manufacture and marketing of fabric care, dishwashing, personal care, and household insecticides products in India and internationally.

JYOTHYLAB

₹404.75

-7.2%

-8.3%

Dabur India

₹900.7b

Operates as a fast-moving consumer goods company worldwide.

500096

₹508.25

-0.5%

-6.0%